David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Caleres
CAL
$438M
| $1.08M | ﹤0.01% |
+34,137
| New | +$1.07M |
|
|
ONCE
2627
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.08M | ﹤0.01% |
+17,993
| New | +$1.19M |
|
|
BV
2628
DELISTED
Bazaarvoice, Inc.
BV
| $1.08M | ﹤0.01% |
184,065
-12,437
| -6% | -$72.3K |
|
|
PSEM
2629
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
| $1.08M | ﹤0.01% |
82,367
+29,892
| +57% | +$405K |
|
|
FCB
2630
DELISTED
FCB Financial Holdings, Inc.
FCB
| $1.08M | ﹤0.01% |
34,008
-9,614
| -22% | -$275K |
|
|
KITE
2631
DELISTED
Kite Pharma, Inc.
KITE
| $1.08M | ﹤0.01% |
17,700
+5,300
| +43% | +$302K |
|
2632
Hormel Foods
HRL
$13.1B
| $1.08M | ﹤0.01% |
+38,238
| New | +$1.08M |
|
|
BRKL
2633
DELISTED
Brookline Bancorp
BRKL
| $1.07M | ﹤0.01% |
95,107
+54,450
| +134% | +$593K |
|
2634
Mizuho Financial
MFG
$126B
| $1.07M | ﹤0.01% |
247,056
-75,167
| -23% | -$302K |
|
|
STBZ
2635
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $1.07M | ﹤0.01% |
49,277
-17,727
| -26% | -$365K |
|
2636
Nu Skin
NUS
$236M
| $1.06M | ﹤0.01% |
+22,509
| New | +$1.22M |
|
2637
Revvity
RVTY
$13.9B
| $1.06M | ﹤0.01% |
20,158
-21,736
| -52% | -$1.13M |
|
|
NGHC
2638
DELISTED
National General Holdings Corp
NGHC
| $1.06M | ﹤0.01% |
50,881
+37,180
| +271% | +$729K |
|
|
ALDR
2639
PUT
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.06M | ﹤0.01% |
+20,000
| New | +$727K |
|
|
GSIG
2640
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $1.06M | ﹤0.01% |
70,439
+542
| +0.8% | +$7.84K |
|
|
TTSH
2641
DELISTED
Tile Shop Holdings
TTSH
| $1.06M | ﹤0.01% |
74,573
-25,092
| -25% | -$338K |
|
|
LMOS
2642
DELISTED
Lumos Networks Corp
LMOS
| $1.06M | ﹤0.01% |
71,508
-7,693
| -10% | -$114K |
|
2643
CALL
Pitney Bowes
PBI
$2.34B
| $1.05M | ﹤0.01% |
50,700
| – | – |
|
2644
TSMC
TSM
$2.16T
| $1.05M | ﹤0.01% |
46,415
-512,775
| -92% | -$12.2M |
|
|
NEWP
2645
DELISTED
NEWPORT CORP
NEWP
| $1.05M | ﹤0.01% |
55,419
+12,710
| +30% | +$246K |
|
2646
Silgan Holdings
SLGN
$4.51B
| $1.04M | ﹤0.01% |
39,548
-21,046
| -35% | -$583K |
|
2647
REX American Resources
REX
$1.37B
| $1.04M | ﹤0.01% |
98,166
-97,446
| -50% | -$1.03M |
|
2648
CALL
Tyson Foods
TSN
$20.1B
| $1.04M | ﹤0.01% |
24,400
| – | – |
|
|
SFXE
2649
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $1.04M | ﹤0.01% |
231,521
+218,573
| +1,688% | +$979K |
|
|
NEWS
2650
DELISTED
NewStar Financial, Inc.
NEWS
| $1.04M | ﹤0.01% |
94,237
-8,311
| -8% | -$92.7K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.